How'd you fix McKesson's revenue issues in 2026?
Direct Answer McKesson's 2026 revenue problem is actually a margin quality issue: US Pharmaceutical revenue grew 18% to $327.7B, but GLP-1 volume dilutes unit economics. The fix requires capturing higher-margin oncology specialty revenue, f…
Read full answer ↗